Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Mol Genet Metab. 2018 Mar 16;124(1):1–10. doi: 10.1016/j.ymgme.2018.03.004

Figure 1.

Figure 1

Growth chart for patients with MPS II from birth to 18 years old, and comparison of mean height between the attenuated and severe phenotype. In Fig. 1A, the dotted line shows the mean height for healthy males and the solid line shows heights for MPS II patients. In Fig. 1B, the dotted line shows the mean height for patients with the attenuated phenotype and the solid line shows the mean height for patients with the severe phenotype. Arrows point to their respective percentile curve. Adapted from Patel et al. (Mol Genet and Metab Rep 1; 2014, 5–18) [8]